Clinical Trial

Large Language Model-Generated Messages to Improve Guideline-Directed Medical Therapy in Heart Failure

Study acronym: LLM-GDMT
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This study is an investigator-initiated, cluster-randomized implementation trial evaluating a large language model (LLM)-based clinical decision support (CDS) tool designed to improve guideline-directed medical therapy (GDMT) for adult patients with heart failure seen in outpatient cardiology clinics at Mass General Brigham. For eligible heart failure encounters, the CDS tool reviews existing electronic health record (EHR) data, including diagnoses, medications, vital signs, laboratory results, and recent notes, and generates brief, clinician-facing messages suggesting opportunities to initiate or optimize GDMT and highlighting relevant safety considerations. Messages are delivered to cardiology providers via Epic InBasket and/or institutional email prior to scheduled visits. The tool is advisory only and cannot place orders or change medications automatically; all treatment decisions remain at the discretion of the treating clinician and patient. Cardiology providers are assigned at the provider/clinic level to early implementation of the CDS tool versus usual care (no messages) during the initial phase. The primary outcome is GDMT optimization within 30 days of an index visit. Secondary outcomes include feasibility of CDS generation and delivery and a 30-day safety composite (e.g., heart failure hospitalization, acute kidney injury, hyperkalemia, hypotension or bradyarrhythmia plausibly related to GDMT).
Protocol Amendment History 2 changes
notable Primary completion pushed: 2027-05-01 -> 2027-07-01 2026-04-22
minor Completion pushed: 2027-09-01 -> 2027-12-01 2026-04-22
Trial Details
NCT Number NCT07337577
Lead Sponsor Brigham and Women's Hospital
Conditions Heart Failure
Enrollment 500 participants
Start Date 2026-06-01
Primary Completion 2027-07-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-21